Journal of Neuro-Oncology

, Volume 118, Issue 2, pp 425–426 | Cite as

ROS1 translocations and amplifications in lung cancer brain metastases

  • Matthias Preusser
  • Berthold Streubel
  • Peter Birner
Letter to the Editor


Brain Metastasis Neuroendocrine Carcinoma Primary Lung Cancer Crizotinib Large Cell Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Davies KD, Doebele RC (2013) Molecular pathways: ROS1 fusion proteins in cancer. Clin Cancer Res 19:4040–4045PubMedCrossRefGoogle Scholar
  2. 2.
    Bergethon K, Shaw AT, Ou SH, Katayama R, Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang R, Mark EJ, Batten JM, Chen H, Wilner KD, Kwak EL, Clark JW, Carbone DP, Ji H, Engelman JA, Mino-Kenudson M, Pao W, Iafrate AJ (2012) ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 30:863–870PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Preusser M, Berghoff AS, Ilhan-Mutlu A, Magerle M, Dinhof C, Widhalm G, Dieckmann K, Marosi C, Wohrer A, Hackl M, Zochbauer-Muller S, von Deimling A, Schoppmann SF, Zielinski CC, Streubel B, Birner P (2013) ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer. Lung Cancer 80:278–283PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Matthias Preusser
    • 1
  • Berthold Streubel
    • 1
  • Peter Birner
    • 1
    • 2
  1. 1.Medical University of ViennaViennaAustria
  2. 2.Ruprecht-Karls Universität HeidelbergHeidelbergGermany

Personalised recommendations